This journal is a member and subscribe the principles of Committee of publication ethics(COPE)U.K,Supports Journal donation project and Free journal act.

Recently published

The Post-treatment Action of Chinonin on MPTP-Induced Mice Model of Parkinson’s Disease.

Zhijian Zhang*, Qingqing Bao, Guoshuai Feng, Sha Li, Jie Jiang

Country: China

To evaluate the protective effects of chinonin on Parkinson’s Disease (PD), we investigated its inhibition in MPP+-induced toxicity in SH-SY5Y cells and its post-treatment action on 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine (MPTP)-induced C57BL/6 mice.Read more

A Fatal Neuroleptic Malignant Syndrome As A Result Of Atypical Antipsychotic Drug Use.

Muhittin Serkan Yilmaz, Miray Baba, Cemil Kavalcı*, Fevzi Yılmaz, Müge Sonmez, Gulsüm Kavalci,Bahattin IÅŸik, Bahadir DaniÅŸman

Country: Turkey

Neuroleptic malignant syndrome (NMS) is a rare but potentially fatal complication of antipsychotic drug use. Its incidence varies between 0.07% and 2.2%. We aimed to report a case with NMS that developed after use of clozapine, an atypical antipsychotic agent.

Healthcare Workers’ Knowledge, Attitudes and Practices in King Fahad Hofuf Hospital, Saudi Arabia.

AL Saleh, Essa M (DrPh)*, Ahmed Ibrahim (PhD) and Mwanri, Lillian (FAFPHM)

Country: Saudi Arabia and Australia

Update situation of Tourette Syndrome.

Fuyong Jiao*, Xiangyang Guo, Xianpeng Yan, Li Wei.


Pharmacologic implications of utilizing amalgamethodology as adaptive trial design in clinical trial research methodology.

Darlene Sredl*

Affilation: University of Missouri-St Louis, One University Boulevard St. Louis, MO 63121-4400.

Stratified medicine approach for systemic sclerosis: state of the art and the need for clinical biomarkers.

*Sam Straw


Login Form

This journal indexed in:-


Editorial Note



Dr. Kal Renganathan Sharma

Department of Physics, College of Science and Technology

Rm 228 Spearman Technology

Bldg.Texas Southern University

3100 Cleburne Street

Houston, TX 77004



Chemical engineering principles can be applied to scale-up formulations of drugs into large production in continuous manner. There are number of advantages for preferring continuous processes over batch modes. The quality will be higher, process cost will be lower. Capital investment and plant costs can be depreciated over reasonable periods of time. Centralized control is possible in continuous processes. The raw materials can be procured in whole sale prices. The finishing operations for the product such as formation of capsules, coating, coloring etc can be sewn into the process flow with benefit. Productivity will be higher and product uniformity will be more. The residence time in the reactors can be lowered and the throughput can be increased. Less manual labor is required. Inventory costs will be on the lower side. Enviromental impact is more benign in the case of continuous process compared with batch mode. Depending on the demand optimal strategies can be devised. Some times space can be minimized for the same throughput. [Read More]


Editor's note

$1000 Genome is within reach


The quest is on to map every known function of every test organism in the universe to the protein signals. Protein signals are linked then to genes in eukoryotes. According to M. Schena who along with his professor Davis pioneered the microarray analysis method in order to obtain sequencing information from gene expression studies, “human disease is going to be eradicated as we know it by the year 2050”.The HGP, human genome project was completed ahead of time. ..................Read more,click on HTML .




[Abstract][View as Html][View as Pdf]

Review article

Systemic sclerosis (SSc) is a highly heterogeneous disease which would benefit from the adoption of a stratified medicine approach, to improve outcomes for patients and reduce costs to the healthcare system. SSc is orphan of disease activity biomarkers, as the current gold standard prognostic test: the modified Rodnan skin score (MRSS) is flawed. The MRSS has been shown to be unreliable, insensitive to change and not specific in measuring skin fibrosis. Physical measurements of skin thickness, genetic risk factors and autoantibodies may all allow patient stratification, however as proteins are the mediators of biological function; proteomics may offer the best approach .................Read more ,click on HTML.


[Abstract][View as Html][View as Pdf]

Upcoming Artcle


Title:- Takotsubo Cardiomyopathy precipitated by positive emotion, recurrence in same patient. Understanding the facts and review of literature.


Takotsubo Cardiomyopathy is a rare but well described entity. The disease is also known as stress induced cardiomyopathy or apical ballooning syndrome. As the name implies, it is usually but not always associated with an antecedent stressful event. Almost all cases of Takotsubo cardiomyopathy are triggered by negative stressors such as anger, grief, and anxiety. Some cases are triggered by physical exertion. Complete recovery is the most common outcome and recurrence is very rare. It is also called broken heart syndrome. It mimics acute coronary syndrome and the correct diagnosis is based on angiographic finding of apical ballooning in absence of significant coronary obstruction. This article reports a unique case of recurrence of Takotsubo cardiomyopathy not described before triggered by a positive emotion in same patient. To our knowledge, this is the only case report of recurrence twice following positive emotion as the trigger in same patient. This patient condition on contrary can be called   happy heart syndrome or may be “laughter disaster”.  The patient had an uneventful course following both episodes. The article also reviews briefly the literature available on etiology, pathogenesis and prognosis.

1.Dr Lakshmi Kant Pathak, MD, MRCP, FACP

Sanford Medical Center

University Of North Dakota, Fargo, USA

2.Dr Chirag Chavda, MD

Methodist Health system, Dallas, USA

3.Dr Mohamed Mohamed, MD

Sanford Medical Center

University Of North Dakota, Fargo, USA

4. Dr Vimala Vijayaraghavan, MD

Caribbean Medical University, Chicago. USA.

CODEN :JPBSCT (Source:ACS),NLM Title Abbreviation: J Pharm Biomed Sci., NLM ID: 10158153


Journal of Pharmaceutical and Biomedical Sciences(J Pharm Biomed Sci.) is a monthly peer-reviewed international member journal  and subscribe principle  of Committee on publication ethics(COPE),Hinari and IMSEAR(Global health library).


The full text is available online at


Scope of Journal


The journal covers Medical (Health & Clinical, Pharmaceutical, Nursing,  Biomedical, Chemistry and Applied Sciences.



Medical and Dentistry: Cover technical and clinical studies related to health, ethical issues in areas of Health sciences and clinical specialties all streams of medicine, dentistry and Biomedical Sciences.


Readers: - All graduates and postgraduates of medical, dentistry and biomedical sciences.

Nursing: Stimulate interest, debate, discussion and interaction among Nursing and specialists of all disciplines within the areas of nursing.

Readers:- Nursing administrators, educators, clinicians, researchers and nursing students.

Pharmaceutical Sciences: All Specialized streams

Readers:- Most of the readers are pharmaceutical and biomedical streams from Asia,UK,Iran,African continent,south Asian continent and USA that frequently read the articles and publish in routine in the different issues.

Chemistry and Chemical Sciences: RRecent research and reviews in chemistry and chemical Sciences.

Readers:- All potential scientists, scholars as well as students in chemistry and chemical Sciences.

Types of article









Abstracting and Indexing Information


The journal is indexed with Committee on publication ethics(COPE), Index Medius of South East Asia (IMSEAR),HINARI,Cite factor,Directory of Research Journal indexing, DOAJ, Google Scholar, GFMER(SWITZERLAND), getcited, Science central, OpenJgate, Library resourses directory, Socol@r, Eastview, Information system, Research,,,CiteseerX , Academic resources (, Journal Donation project (JDP), PSOAR and PGAIR,British Library,Electrinic journal Library,Poding memorial library, OhioLink,Kaohsiung Medical University Library, Lenketjenester Universitetsbiblioteketi Oslo,Syracuse University Library,Feng Chia Unversity, Indiana University,Bibliotheque Michel Serres (Ecole Centrale  Lyon), EditLib, Dayang Journal system (Korea), UlrichsWeb Directory (Proquest), Biblioteca Universia, IBLIO TECA(CCG-IBT),Birmingham Public library, and having positive response from Forest Products Abstracts, CABI, UK, Botanical Pesticides Abstracts, CABI, UK, AgBiotechNet, CABI, UK, Academic Resources(, Sirus, New Jour ( Lauinger Library, George, Georgetown University, Washington), POPLINE (Johns Hopkins Bloomberg School of Public Heath, USA ), World Association of Medical Editors (WAME), National of agriculture library, USA (AGRICOLA), MysiteseerX, SCOPUS (Elsevier),Connect journals,IMSEAR,HINARI  many more...............................................

Journal of Pharmaceutical and Biomedical Sciences (J Pharm Biomed Sci.) recently  indexed in ACS, Chemical abstract service (CAS), Library Resource directory, WorldCat, Asian Science Citation Index(ASCI), Indian , NKRC  ( National Knowledge resource consortium), Govt of India, MedNAR, Science Research.

Authors benefit

1- Round the clock editorial support.

2-Proof reading by English proof readers and automatic proof reading software (Proof file will be provided only after acceptance of the article).

3-Grammer check (Automatic system), report after acceptance.

4-Plagarism check (I-authenticate and Viber), report and score only after acceptance of article.

5-Quick article processing and QRP only on author's request.

6- Article published in the most advanced publication system (PDF, HTML, XML [NLM DTD 3.0 validated], e-pub and mobile text from August onwards.

Submit articles

at This e-mail address is being protected from spambots. You need JavaScript enabled to view it or This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Journal Statistics and IF
Journal Statistics and *Impact factor:

*IF(2010-2013)= 2.14,

h-index= 16,





[*h-index and impact factor calculated on the basis of scholar h-index calculator.

Latest Modification

26-02-2015 17:54
ISSN 2230 – 7885
Who's Online
We have 243 guests online
mod_vvisit_counterAll days4187056

Today: Feb 27, 2015
Google Scholar
Copyright© 2013.,